MEDSIR hosted the 2nd edition of the GU Brainstorming Series, focusing on advancing research in urothelial carcinoma, renal cell carcinoma, and rare genitourinary indications including penile and testicular carcinoma.
Distinguished oncologists Dr. Joan Carles (Vall d'Hebron Institute of Oncology, Barcelona), Dr. Pablo Maroto (Hospital de la Santa Creu i Sant Pau, Barcelona), Dr. Rafael Morales (Vall d'Hebron Institute of Oncology, Barcelona), and Dr. Javier Molina (Ramón y Cajal Hospital, Madrid) convened at the MEDSIR headquarters in Barcelona.
Felipe Slebe, our Strategic Research Development Manager, extended a warm welcome to our esteemed guests and facilitated the session. The primary aim was to explore recent advancements in clinical research and stimulate innovative ideas for investigator-initiated clinical trials (IITs) addressing critical unmet needs in the field.
The session benefitted from the participation of experts from our Data Analytics and Translational Departments, ensuring a comprehensive discussion encompassing statistical methodologies and the potential integration of translational components into trial designs.
Commencing with an overview of the current clinical landscape in urothelial carcinoma, the discussion transitioned to strategies for adapting to upcoming changes in the standard of care. Subsequently, attention shifted to renal cell carcinoma, with a focus on identifying novel biomarkers and designing trials to mitigate treatment-related toxicities. The session concluded with an exploration of unmet needs in rare genitourinary indications, underscoring the importance of addressing gaps in research for conditions such as penile and testicular cancer.
Through collaborative efforts and the expertise of our participants, the session sparked insightful debates and generated innovative ideas for IITs targeting identified unmet needs.
In summary, the session was a resounding success, characterized by the emergence of innovative ideas and fruitful networking with globally renowned oncologists. We are excited to implement their suggestions into meaningful clinical trials.
Are you interested in participating in future brainstorming sessions? Reach out to us, and let's explore potential collaborations together.
Comments